Table 2 Differences in patient-reported outcomes and OMERACT-OARSI responders between the intervention and control group at 3 and 6 months follow-up
Intervention group | Control group | Control vs. intervention 3 mos. (95% CI) | p | Control vs. intervention 6 mos. (95% CI) | p | Control vs. Intervention group 3 + 6 mos. (95% CI) | p | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BL n = 283 | 3 mos. n = 242 | 6 mos. n = 239 | 3 + 6 mos. | BL n = 109 | 3 mos. n = 106 | 6 mos. n = 106 | 3 + 6 mos. | |||||||
Pain last week (NRS 0–10), mean (SD) | 5.4 (2.0) | 4.4 (2.0) | 4.2 (2.1) | 5.1 (1.8) | 4.7 (2.2) | 4.7 (2.1) | b: −0.65 (−1.26, −0.04) | 0.04 | b: − 0.98 (− 1.59, − 0.37) | 0.002 | ||||
Function last week (NRS 0–10), mean (SD) | 5.2 (2.0) | 4.4 (1.9) | 4.1 (2.1) | 4.9 (1.9) | 4.6 (2.3) | 4.7 (2.1) | b: −0.67 (−1.28, − 0.06) | 0.03 | b: − 1.17 (− 1.78, − 0.56) | < 0.001 | ||||
Disease activity last week (NRS 0–10), mean (SD) | 5.3 (2.0) | 4.3 (2.0) | 4.2 (2.1) | 4.8 (2.0) | 4.7 (2.3) | 4.7 (2.2) | b: −0.93 (−1.55, − 0.31) | 0.003 | b: − 1.02 (− 1.64, − 0.39) | 0.001 | ||||
OMERACT-OARSI responders, n (%) | 92 (33) | 99 (35) | 132 (47) | 24 (23) | 24 (23) | 36 (35) | OR: 1.37 (0.26, 7.24) | 0.7 | OR: 2.81 (0.32, 24.67) | 0.3 | OR: 1.38 (0.41, 4.67) | 0.6 | ||
Stiffness last week (NRS 0–10), mean (SD) | 5.3 (2.3) | 4.5 (2.1) | 4.3 (2.1) | 4.9 (2.2) | 4.6 (2.1) | 4.9 (2.1) | b: −0.63 (−1.28, 0.01) | 0.05 | b: − 1.10 (− 1.74, − 0.45) | 0.001 | ||||
H/KOOS QoL subscale mean (SD) | 44.9 (16.3) | 47.8 (14.9) | 49.7 (15.8) | 49.9 (17.2) | 45.3 (18.2) | 47.2 (17.5) | b: 5.43 (0.59, 10.27) | 0.03 | b: 5.11 (0.28, 9.95) | 0.04 | ||||
Daily hours in sitting position, mean (SD) | 6.5 (2.8) | 6.1 (2.8) | 5.9 (2.6) | 6.8 (3.6) | 6.4 (3.2) | 6.2 (3.0) | b:-1.17 (−2.04, −0.31) | 0.008 | b: −1.47 (− 2.33, − 0.60) | 0.001 | ||||